Comparing Epidiolex vs Fintepla
| Epidiolex (cannabidiol) | Fintepla (fenfluramine) |
|
|---|
| Epidiolex (cannabidiol) | Fintepla (fenfluramine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Lennox-Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex. Epidiolex may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lennox-Gastaut Syndrome, Dravet Syndrome. Fintepla may also be used for purposes not listed in this medication guide. |
Related suggestions Lennox-Gastaut Syndrome
Dravet Syndrome
|
|||||||||||||||
| More about Epidiolex (cannabidiol) | More about Fintepla (fenfluramine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Epidiolex has an average rating of 3.7 out of 10 from a total of 3 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 67% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Epidiolex prices |
View all Fintepla prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
61 hours |
20 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 610 drugs are known to interact with Epidiolex:
|
A total of 575 drugs are known to interact with Fintepla:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
June 25, 2018 |
June 25, 2020 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.